Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Savastano, Silvia ^a   Di Somma, Carolina ^b   Pizza, Genoveffa ^a   De Rosa, Annalba ^a   Nedi, Valeria ^a   Rossi, Annalisa ^a   Orio, Francesco ^c   Lombardi, Gaetano ^a   Colao, Annamaria ^a   Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL FAT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMPEDANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; SPLEEN SIZE; ANTHROPOMETRY; ECHOGRAPHY; ENZYMOLOGY; MENOPAUSE; METABOLISM; PATHOLOGY; SPLEEN;

ADIPOSITY; ADULT; ANTHROPOMETRY; ASPARTATE AMINOTRANSFERASES; C-REACTIVE PROTEIN; FATTY LIVER; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER; MENOPAUSE; OBESITY; SPLEEN;

EID: 80051615349     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-136     Document Type: Article

References (29)

1. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010, 17:332-341. 10.5551/jat.3939, 20124732.
2. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007, 22:293-303. 10.1111/j.1440-1746.2007.04824.x, 17295757.
3. Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno MN, Chianese D, Pasanisi F, Contaldo F, Scopacasa F, Capone D. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?. J Transl Med 2008, 6:72. 10.1186/1479-5876-6-72, 2611972, 19038040.
4. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009, 51:1061-1067. 10.1016/j.jhep.2009.09.001, 19846234.
5. Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 2005, 4:196-200.
6. Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?. J Inflamm 2009, 6:6.
7. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?. Eur J Gastroenterol Hepatol 2009, 21:504-511. 10.1097/MEG.0b013e3283229b40, 19318968.
8. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Res 2003, 13:113-170. 10.1016/S1096-6374(03)00038-8, 21845579.
9. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-1 function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008, 252:91-110. 10.1016/j.cellimm.2007.09.010, 2615236, 18325486.
10. Völzke H, Nauck M, Rettig R, Dörr M, Higham C, Brabant G, Wallaschofski H. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol 2009, 161:705-713. 10.1530/EJE-09-0374, 19690083.
11. Andreassen M, Raymond I, Hildebrandt P, Kistorp C, Rathcke C, Vestergaard H, Faber J, Kristensen LO. Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population. Inflamm Res 2010, 59:503-510. 4, 10.1007/s00011-009-0154-z, 20047081.
12. Svensson J, Lönn L, Johannsson G, Bengtsson BA. Effects of GH and insulin-like growth factor-I on body composition. J Endocrinol Invest 2003, 26:823-831.
13. Lamberts SW, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998, 352:127-134.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, (Supp. 1):S5-S20.
15. National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH Publication No. 02-5215 2002,
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
17. Oscarsson J, Johannsson G, Johannsson JO, Lundeberg PA, Lindstedt G, Bengtsson BA. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentration during daily subcutaneous injection of recombinant human growth hormone in GH-deficient adults. J Clin Endocrinol Metab 1997, 46:63-68.
18. Piccoli A, Brunani A, Savia G, Pillon L, Favaro E, Berselli ME, Cavagnini F. Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes 1998, 22:97-104.
19. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, Oren R. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009, 192:909-914. 10.2214/AJR.07.4016, 19304694.
20. Wasada T, Kasahara T, Wada J, Jimba S, Fujimaki R, Nakagami T, Iwamoto Y. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity. Metabolism 2008, 57:980-985. 10.1016/j.metabol.2008.02.015, 18555841.
21. Maddux BA, Chan A, De Filippis EA, Mandarino LJ, Goldfine ID. IGF-binding protein-1 levels are related to insulin mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 2006, 29:1535-1537. 10.2337/dc05-1367, 16801575.
22. von Laue S, Ross RJ. Inflammatory cytokines and acquired growth hormone resistance. Growth Horm IGF Res 2000, (Suppl B):S9-14.
23. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr Opin Clin Nutr Metab Care 2003, 6:295-259.
24. Savastano S, Di Somma C, Belfiore A, Guida B, Orio F, Rota F, Savanelli MC, Cascella T, Mentone A, Angrisani L, Lombardi G, Colao A. Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest 2006, 29:536-543.
25. Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol 2010, 25(316):147-153.
26. Savastano S, Belfiore A, Di Somma C, Mauriello C, Rossi A, Pizza G, De Rosa A, Prestieri G, Angrisani L, Colao A. Validity of bioelectrical impedance analysis to estimate body composition changes after bariatric surgery in premenopausal morbidly women. Obes Surg 2010, 20:332-339. 10.1007/s11695-009-0006-5, 19862582.
27. Yoshioka K, Kawabe N, Hashimoto S. Transient elastography: Applications and limitations. Hepatol Res 2008, 38:1063-1068. 10.1111/j.1872-034X.2008.00386.x, 18624715.
28. Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cardenas E, Sanchez-Avila F, Vargas-Vorackova F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol 2008, 7:350-357.
29. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011, 21:87-97. 10.1007/s00330-010-1905-5, 2995875, 20680289.